Inhalable oxytocin a potential treatment for postpartum haemorrhage

Press/Media: Article/Feature

Period21 Mar 2019

Media contributions

1

Media contributions

  • TitleInhalable oxytocin a potential treatment for postpartum haemorrhage
    Degree of recognitionInternational
    Media name/outletPharmaceutical Technology
    Media typeWeb
    Date21/03/19
    DescriptionInhalable oxytocin may be used in resource-limited states to manage postpartum haemorrhage, as the result of a research agreement between Janssen Pharmaceutica, a Johnson & Johnson unit, and the Monash University’s Monash Institute of Pharmaceutical Sciences (MIPS).
    URLhttps://www.pharmaceutical-technology.com/news/inhalable-oxytocin/
    PersonsMichelle McIntosh
View all 1
View less